Examinando por Autor "Bartolo Ladera, Erica Jesusa"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Interacciones medicamentosas potenciales en las prescripciones médicas de pacientes COVID-19 de la unidad de cuidados intensivos del hospital María Auxiliadora. marzo a diciembre 2020
    (Universidad Privada Norbert Wiener, 2021-08-12) Camacho Camacho, Jorge Luis; Bartolo Ladera, Erica Jesusa; Torres Veliz, Ernesto Raúl
    The present research aims to identify "potential drug interactions in medical prescriptions attended in the Intensive Care Unit of COVID 19 patients of the María Auxiliadora hospital in the period. March to December 2020." The research is applied, retrospective, observational-cross-sectional. For this purpose, information was collected through medical prescriptions, the study population was made up of 1279 medical prescriptions, the analysis sample was 220 prescriptions at a 95% confidence level, where the data collection instrument was used included in four dimensions: Type of Interaction, Pharmacotherapeutic Group, Degree of Severity, Number of Interactions. Of the PMIs, a total of 870 were found; with respect to the type of interactions 568(65.3%) correspond to pharmacodynamics 250(28.7%) are pharmacokinetic and 52(6.0%) are unknown, corresponding to the pharmacotherapeutic group the most frequent was narcotic analgesics with 278(16.0%) of interactions followed by sedative-hypnotics with 258(14.8%), followed by antiulcer drugs with 144(8.3%), followed by neuromuscular blockers with 139(8.0%), followed by antipsychotics with 123(7.1%), followed by antiasthmatics 118(6.8%) followed by diuretics 93(5.3%), followed by corticosteroids with 75(4.3%). In terms of severity, we have moderate with 555 (64.0%), followed by high with 191 (22.0%), followed by the lowest with 124 (14.0%). Regarding the number of interactions per prescription, we have: with 1 interaction per prescription 17 (7.7%) with 2 interactions 13 (5.9%) with 3 interactions 35 (15.9%) with 4 interactions 37 (16.8%), with 5 interactions 24 (10.9%), finally, out of a total of 220 prescriptions, 33 (15.0%) did not present IMP and 187 (85.0%) presented IMP interactions.